Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Residency Update

30 Jan 2018 07:00

RNS Number : 2599D
Phoenix Group Holdings
30 January 2018
 

Phoenix Group Holdings

LEI: 21380031B1D56JRCE375

Notice to PGH shareholders and to holders of outstanding debt securities regarding change in the head office and tax residence of Phoenix Group Holdings ("PGH")

Further to the announcement dated 21 June 2017, notice is hereby given that with effect from 31 January 2018 the central management and control, and the head office, of PGH will move from Jersey to the United Kingdom, with the intention that PGH will be resident in the United Kingdom for tax purposes from such date.

With effect from 31 January 2018, the PRA will treat PGH, and not Phoenix Life Holdings Limited ("PLHL"), as the ultimate EEA insurance holding company of the Insurance Group.

Holders of the subordinated securities:

· £428,113,000 6.625 per cent. Guaranteed Subordinated Notes due 2025;

· £450,000,000 4.125 per cent. Tier 3 Notes due 2022 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme; and

· U.S.$500,000,000 5.375 per cent. Notes due 2027 issued pursuant to PGH's £3,000,000,000 Euro Medium Term Note Programme,

each issued by PGH (together, the "Outstanding Subordinated Securities"), are hereby notified that as such, PGH will become the ultimate EEA insurance holding company and the Insurance Group Parent Entity and a member of the Insurance Group for the purposes of the terms and conditions of the Outstanding Subordinated Securities. This will result in the Outstanding Subordinated Securities (and not the relevant on-loan of the proceeds of the Outstanding Subordinated Securities) being the only relevant capital item for the purposes of the definition of "Capital Disqualification Event" under the Outstanding Subordinated Securities with effect from such date.

PLHL will no longer be required by the PRA to be taken into account for the purposes of the deferral of principal and interest on the Outstanding Subordinated Securities pursuant to the definitions of "Regulatory Deficiency Interest Deferral Event" and "Regulatory Deficiency Redemption Deferral Event".

Capitalised terms that are not defined in this announcement will have the meanings given to them in the terms and conditions of the Outstanding Subordinated Securities.

The change in tax residency is not expected to impact PGH shareholders, other than UK stamp duty reserve tax (currently levied at 0.5%) will be incurred on subsequent purchases of PGH depositary interests.

Any PGH shareholder who is uncertain of the implications of the change in PGH's tax residency on their investment is recommended to obtain professional advice.

The change in tax residency will not impact the terms and conditions of the ÂŁ300,000,000 5.75 per cent. Bonds due 2021 (of which ÂŁ121,610,000 remains outstanding).

For further information, please contact:

 

Debt investors:

Rashmin Shah, Group Treasurer, Phoenix Group

Telephone: +44 (0) 20 3735 0059

Email: rashmin.shah@thephoenixgroup.com

 

Equity investors/analysts:Sam Perowne, Head of Investor Relations, Phoenix GroupTelephone: +44 (0) 20 3735 0021

Email: Samuel.Perowne@thephoenixgroup.com

 

 

Website: www.thephoenixgroup.com

 

This notice does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSEDFWUFASEDF
Date   Source Headline
14th Mar 20259:00 amRNSBoard Change
6th Mar 20253:35 pmRNSDirector/PDMR Shareholding
3rd Mar 202511:12 amRNSTotal Voting Rights
6th Feb 20254:12 pmRNSDirector/PDMR Shareholding
5th Feb 20255:41 pmRNSCompletion of Early Redemption
3rd Feb 20255:47 pmRNSTotal Voting Rights
7th Jan 20252:19 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:00 amRNSTotal Voting Rights
2nd Jan 20258:30 amRNSAnnouncement of Early Redemption
12th Dec 20244:35 pmRNSBlock Listing Application
12th Dec 20244:11 pmRNSBlock listing Return
6th Dec 20245:39 pmRNSDirector/PDMR Shareholding
4th Dec 20249:00 amRNSDirectorate Change
2nd Dec 20241:32 pmRNSTotal Voting Rights
6th Nov 20245:48 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSDirectorate Change
5th Nov 20249:22 amRNSDirector/PDMR Shareholding
1st Nov 202412:48 pmRNSDirector/PDMR Shareholding
1st Nov 202412:43 pmRNSTotal Voting Rights
22nd Oct 20244:19 pmRNSDirector/PDMR Shareholding
8th Oct 20245:24 pmRNSDirector/PDMR Shareholding
4th Oct 20243:35 pmRNSDirector/PDMR Shareholding
1st Oct 202410:56 amRNSTotal Voting Rights
18th Sep 202410:56 amRNSDirector/PDMR Shareholding
17th Sep 202411:09 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNS2024 Interim Results
10th Sep 20243:54 pmRNSDirector/PDMR Shareholding
6th Sep 20248:58 amRNSMajor Shareholding
2nd Sep 202411:08 amRNSTotal Voting Rights
28th Aug 20249:16 amRNSDirectorate Change
6th Aug 20245:02 pmRNSDirector/PDMR Shareholding
1st Aug 20241:28 pmRNSTotal Voting Rights
8th Jul 20245:44 pmRNSDirector/PDMR Shareholding
1st Jul 20244:32 pmRNSTotal Voting Rights
26th Jun 20247:00 amRNSPhoenix Group to explore the sale of SunLife
20th Jun 20247:00 amRNSDeleveraging Programme Update
14th Jun 20248:14 amRNSResult of Tender Offer
11th Jun 20241:51 pmRNSBlock listing Return
10th Jun 20244:15 pmRNSPublication of Offering Memorandum
6th Jun 20245:14 pmRNSDirector/PDMR Shareholding
6th Jun 20242:11 pmRNSIssue of debt and tender maximum acceptance amount
5th Jun 20247:29 amRNSTender Offers and New Issue
3rd Jun 20241:27 pmRNSTotal Voting Rights
24th May 202411:05 amRNSDirector/PDMR Shareholding
14th May 20242:43 pmRNSResult of AGM
13th May 20247:00 amRNSDirectorate Change
8th May 20244:33 pmRNSDirector/PDMR Shareholding
3rd May 202411:04 amRNSAnnouncement of Early Redemption
1st May 202411:23 amRNSTotal Voting Rights
12th Apr 20244:41 pmRNSSupplemental Circular to the 2024 Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.